Result: Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy

*Title*:

Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy / Olivier Karl Friedrich Ballo [und weitere]

*Author/editor-in-chief*:

Ballo, Olivier (Verfasser)

*Published in*:

Annals of hematology. - Berlin ; Heidelberg ; New York : Springer, 24.09.2020. - Seite 2547-2553. - 10.1007/s00277-020-04274-1. - ISSN 1432-0584. - Jahrgang 99, Heft 11

*Publication*:

Berlin ; Heidelberg ; New York : Springer, 24.09.2020

*Distribution*:

Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg

*Physical description scale*:

1 Online-Ressource (7 Seiten)

*Format*:

*eBook*

*Language*:

*eng*

*DOI*:

10.1007/s00277-020-04274-1

*oa_rights*:

Open Access
CC BY 4.0

*Result*: Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy

*Additional information*

*Additional functions*

Result: Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy

Additional information

Additional functions